Fig. 12

Participation in clinical trials using 3D/AM according to the results of the 2 studies (study 1 in 2019–20 and study 2 in 2022–23)
Participation in clinical trials using 3D/AM according to the results of the 2 studies (study 1 in 2019–20 and study 2 in 2022–23)